Difference between revisions of "Xiong YQ, et al. Clin. Cancer Res. (2009) cited as Ref 25 in DOI: 10.1038/s41392-020-0110-5 (Q9288)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 15, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells, #quickstatements; #temporary_batch_159...) |
||
| Property / title | |||
| + | Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells (English) | ||
| Property / title: Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells (English) / rank | |||
| + | Normal rank | ||
Revision as of 21:43, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Xiong YQ, et al. Clin. Cancer Res. (2009) cited as Ref 25 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Xiong YQ
0 references
2009
0 references
Clin. Cancer Res.
0 references
15
0 references
Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells (English)
0 references
